Literature DB >> 8088331

A 150-kDa molecule of macrophage membrane stimulates interleukin-2 and interferon-gamma production and proliferation of ovalbumin-specific CD4+ T cells.

J N Agrewala1, D S Vinay, A Joshi, G C Mishra.   

Abstract

In the present study, we describe the potential co-stimulatory role of a macrophage membrane-associated protein of 150 kDa (M150). The protein was isolated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and was found to be a single molecule on two-dimensional gel electrophoresis. The molecule was re-constituted in phosphatidyl choline vesicles and tested for its ability to promote the proliferation and the secretion of lymphokines from T helper (Th) cells. The reconstituted M150 induced a significant proliferation of anti-CD3 monoclonal antibody (mAb)-stimulated ovalbumin-specific CD4+ T cells. Further, Th cells activated with this molecule in the presence of anti-CD3 mAb mainly secreted interleukin (IL)-2 and interferon-gamma but not IL-4. M150 could not promote the proliferation of Th cells, or lymphokine secretion in the absence of anti-CD3 mAb. These observations suggest that M150 acts by selectively activating a Th1-like immune response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088331     DOI: 10.1002/eji.1830240924

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Apoptosis of Th1-like cells in experimental tuberculosis (TB).

Authors:  G Das; H Vohra; B Saha; J N Agrewala; G C Mishra
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

2.  Regulation of secretion of IL-4 and IgG1 isotype by melatonin-stimulated ovalbumin-specific T cells.

Authors:  A V Shaji; S K Kulkarni; J N Agrewala
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

3.  Modulation of the expression of M150 on macrophages by Th1/Th2 cytokines and co-stimulatory molecules CD40, B7-1, B7-2 and ICAM-1.

Authors:  S Suvas; H Vohra; J N Agrewala
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.